BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 36425786)

  • 21. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
    Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
    Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
    Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
    [No Abstract]   [Full Text] [Related]  

  • 24. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer.
    Mehdi AM; Zhou C; Turrell G; Walpole E; Porceddu S; Frazer IH; Chandra J
    Cancer Gene Ther; 2023 Apr; 30(4):629-640. PubMed ID: 36575316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
    Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
    J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
    Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
    Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Chintala S; Quist KM; Gonzalez-DeWhitt PA; Katzenellenbogen RA
    Head Neck; 2022 Jan; 44(1):177-188. PubMed ID: 34693597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment.
    He Y; Xiang J; Li Y; Huang W; Gu F; Wang Y; Chen R
    Cancer Med; 2023 Jun; 12(11):12622-12638. PubMed ID: 37076985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
    Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs.
    Khan IN; Gibson-Corley KN; Coppock JD; Simons AL
    Head Neck Pathol; 2022 Sep; 16(3):763-772. PubMed ID: 35334093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
    Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
    Shi E; Wu Z; Karaoglan BS; Schwenk-Zieger S; Kranz G; Abdul Razak N; Reichel CA; Canis M; Baumeister P; Zeidler R; Gires O
    J Biomed Sci; 2023 Aug; 30(1):72. PubMed ID: 37620936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments.
    Carrero I; Liu HC; Sikora AG; Milosavljevic A
    Oncogene; 2019 May; 38(19):3551-3568. PubMed ID: 30655605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
    Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.